The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise (Q34136647)

31 July 2017

The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise (English)

1 reference

31 July 2017

1 reference

Council of the Global HIV Vaccine Enterprise

series ordinal

1

1 reference

PubMed ID

20823883

31 July 2017

language of work or name

English

0 references

publication date

1 September 2010

1 reference

31 July 2017

1 reference

31 July 2017

16

1 reference

31 July 2017

9

1 reference

31 July 2017

981-989

1 reference

https://scigraph.springernature.com/pub.10.1038/nm0910-981

31 July 2017

0 references

cites work

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

1 reference

12 December 2020

Public health. Global HIV/AIDS policy in transition

1 reference

12 December 2020

The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan

1 reference

12 December 2020

Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge

1 reference

12 December 2020

STEP study: disappointing, but not a failure

1 reference

12 December 2020

Post-step modifications for research on HIV vaccines

1 reference

12 December 2020

The immune response during acute HIV-1 infection: clues for vaccine development

1 reference

12 December 2020

A prescription for human immunology

1 reference

12 December 2020

Challenges for structure-based HIV vaccine design

1 reference

12 December 2020

Fc receptor but not complement binding is important in antibody protection against HIV.

1 reference

12 December 2020

Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants.

1 reference

12 December 2020

Targeting early infection to prevent HIV-1 mucosal transmission.

1 reference

12 December 2020

Medicine. The need for a global HIV vaccine enterprise

1 reference

12 December 2020

Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques

1 reference

12 December 2020

HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses

1 reference

12 December 2020

Immunology and the elusive AIDS vaccine

1 reference

12 December 2020

HIV molecular epidemiology: transmission and adaptation to human populations

1 reference

12 December 2020

An HIV vaccine--challenges and prospects

1 reference

12 December 2020

Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates

1 reference

12 December 2020

Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03).

1 reference

12 December 2020

Genetic and antigenic features of the transmitted virus

1 reference

12 December 2020

Neuroscience in the era of functional genomics and systems biology

1 reference

12 December 2020

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

1 reference

12 December 2020

Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers

1 reference

12 December 2020

Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection

1 reference

12 December 2020

Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology

1 reference

12 December 2020

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target

1 reference

12 December 2020

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

1 reference

12 December 2020

Antibody-based HIV-1 vaccines: recent developments and future directions

1 reference

12 December 2020

Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals

1 reference

12 December 2020

Improving defences at the portal of HIV entry: mucosal and innate immunity

1 reference

12 December 2020

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

1 reference

12 December 2020

Common genetic variation and the control of HIV-1 in humans

1 reference

12 December 2020

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM0910-981

1 reference

31 July 2017

1 reference

PubMed ID

20823883